Internal Medicine, Pulmonary Disease · Sewell, NJ
NPI
1093785487
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
100a Kings Way West
Sewell, NJ, 08080
Phone (856) 218-8080
Groups this clinician bills Medicare through
Medicare paid, 2024
$270K
3,328 services
Medicare patients, 2024
822
Average age 75
Drug cost, 2024
$3.6M
3,795 prescriptions
Company payments, 2025
$1,662
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos A Obregon was code 99215 (office e&m - established), 1,255 times for 714 patients. In total Carlos A Obregon billed 3,328 services in 35 codes, and Medicare paid $270K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,255 | 714 | $129.07 | $162K |
| 94010 Pulmonary Function Testing | Office | 719 | 505 | $20.65 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 324 | 99 | $87.67 | $28K |
| 99232 Hospital E&M - Subsequent | Facility | 176 | 65 | $58.91 | $10K |
| 99223 Hospital E&M - Initial | Facility | 130 | 107 | $126.23 | $16K |
| 94727 Pulmonary Function Testing | Office | 72 | 71 | $34.27 | $2,467 |
| 94729 Pulmonary Function Testing | Office | 71 | 70 | $43.68 | $3,101 |
| 94640 Treatment - Miscellaneous | Office | 61 | 61 | $6.27 | $383 |
| 99205 Office E&M - New | Office | 60 | 60 | $154.32 | $9,259 |
| 94060 Pulmonary Function Testing | Office | 59 | 59 | $30.28 | $1,786 |
| 31652 Bronchoscopy | Facility | 34 | 34 | $157.67 | $5,361 |
| 99407 Behavioral Health Services | Office | 32 | 28 | $25.89 | $829 |
| 95806 Sleep Study | Office | 22 | 21 | $35.60 | $783 |
| 31624 Bronchoscopy | Facility | 18 | 18 | $98.75 | $1,778 |
| 31628 Bronchoscopy | Facility | 18 | 18 | $88.92 | $1,601 |
By year: 2022 $254K for 2,522 services; 2023 $244K for 2,603 services; 2024 $270K for 3,328 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos A Obregon prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 454 prescriptions and refills. In total Carlos A Obregon wrote 3,795 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 454 | 587 | 207 | $16K |
| Arnuity Ellipta Fluticasone Furoate | 316 | 537 | 91 | $122K |
| Montelukast Sodium Generic | 311 | 859 | 124 | $4,555 |
| Furosemide Generic | 300 | 821 | 123 | $1,894 |
| Prednisone Generic | 211 | 280 | 151 | $954 |
| Breo Ellipta Fluticasone/Vilanterol | 196 | 270 | 57 | $103K |
| Fluticasone Propionate Generic | 191 | 382 | 104 | $5,035 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 158 | 219 | 52 | $25K |
| Eliquis Apixaban | 84 | 100 | 19 | $56K |
| Opsumit Macitentan | 77 | 77 | Under 11 | $1.0M |
| Sildenafil Citrate Generic | 60 | 70 | Under 11 | $15K |
| Qvar Redihaler Beclomethasone Dipropionate | 57 | 111 | 26 | $29K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 56 | 92 | 26 | $57K |
| Bumetanide Generic | 53 | 130 | 18 | $1,367 |
| Azithromycin Generic | 51 | 60 | 43 | $398 |
Brand drugs: 1,781 claims; generic drugs: 2,014 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos A Obregon $1,662 ($1,662 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $354.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $354 |
| Insmed, Inc. INSM | 13 | $250 |
| Genzyme Corporation SNY | 17 | $233 |
| GlaxoSmithKline, LLC. GSK | 18 | $217 |
| Actelion Pharmaceuticals US, Inc. JNJ | 9 | $136 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $77.62 |
| Verona Pharma, Inc. VRNA | 4 | $62.37 |
| Grifols USA, LLC | 3 | $61.02 |
| Amgen Inc. AMGN | 2 | $51.05 |
| Axsome Therapeutics, Inc. AXSM | 3 | $46.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.